The influence of experimentally-induced endotoxaemia on clinical variables and markers of systemic inflammation in donkeys (Equus asinus)
In view of the frequent involvement of endotoxins in the pathogenesis of equine diseases, the present study set out to gain preliminary insight into the challenge caused by lipopolysaccharide (LPS) exposure in donkeys and into the responses of animals to LPS challenge. To the best of our knowledge, this is the first study to determine the susceptibility and response of donkeys to LPS administration and the first to describe the extent to which donkeys can tolerate a state of endotoxaemia. For this purpose, 18 clinically healthy, native breed donkeys were randomly allocated into three groups of equal size. The first and second groups received E. coli O55:B5 endotoxin at a dose rate of 20 ng/kg (Low dose group), and 5.0 µg/kg (High dose group), respectively, after dilution in 500 ml of 0.9% normal saline, while the third group (Control) received 500 ml of 0.9% isotonic saline solution. Blood samples were drawn from each animal before exposure to LPS and hourly for 6 h subsequently to measure the circulating levels of inflammatory cytokines as well as the cellular response. All animals were clinically monitored throughout the study period. Following LPS exposure, donkeys in both treated groups had quite different temporal patterns of clinical manifestations. The high dose of LPS yielded a statistically significant (P < 0.001 and P < 0.001, respectively) increase in heart rate, and respiratory rate, as well as hypothermia and poor outcome compared with animals receiving the low dose. The severity of colic was, in general, mild in donkeys receiving the low dose of LPS, while the signs were overt in those receiving the high dose. Donkeys of both treated groups exhibited marked cellular alterations and up-regulation of tumour necrosis factor alpha, interleukin (IL)-12 and IL-10 with a marginal increase in the values of serum amyloid A compared with controls (P < 0.05). The results described herein demonstrate that donkeys can respond to even a physiological dose of E. coli O55:B5 endotoxin, while a high dose can elicit overt clinical alterations and marked inflammatory responses. Further studies with an extended follow-up time are needed to verify and generalise the obtained findings and to evaluate novel medications to minimise the deleterious consequences of endotoxaemia in equine patients.
Bone Roger C. (1991): The Pathogenesis of Sepsis. Annals of Internal Medicine, 115, 457-
https://doi.org/10.7326/0003-4819-115-6-457
Corley Kevin, McKenzie Harold, Amoroso Lisa, Furr Martin (2000): Initial Experience with Norepinephrine Infusion in Hypotensive Critically III Foals. Journal of Veterinary Emergency and Critical Care, 10, 267-276
https://doi.org/10.1111/j.1476-4431.2000.tb00012.x
FAOSTAT − Food and Agricultural Organization of the United Nations (2013): FAO statistical database. Food and Agricultural Organization of the United Nations. Available at http://faostat.fao.org/.
Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O’Garra A (1991): IL-10 inhibits cytokine production by activated macrophages. Journal of Immunology 147, 3815–3822.
Freeman L, Paradis MR (1992): Evaluating the effectiveness of equine neonatal care. Veterinary Medicine 87, 921–926.
King J., Gerring E. (1988): Detection of endotoxin in cases of equine colic. Veterinary Record, 123, 269-271
https://doi.org/10.1136/vr.123.10.269
McGovern K.F., Lascola K.M., Smith S.A., Clark-Price S.C., Wilkins P.A., Schaeffer D.J., Foreman J.H. (2013): The Effects of Hyperglycemia and Endotoxemia on Coagulation Parameters in Healthy Adult Horses. Journal of Veterinary Internal Medicine, 27, 347-353
https://doi.org/10.1111/jvim.12052
McKenzie HC, Furr MO (2001): Equine neonatal sepsis: The pathophysiology of severe inflammation and infection. Compendium: Equine Edition 2, 661–670.
Moore JN (2001): II. A perspective on endotoxaemia. In: Proceedings of the Annual Convention of the AAEP, 2001. San Diego, USA. 61–74.
MOORE J. N., NORTON N., BARTON M. H., HURLEY D. J., REBER A. J., DONOVAN D. C., VANDENPLAS M. L., PARKER T. S., LEVINE D. M. (2007): Rapid infusion of a phospholipid emulsion attenuates the effects of endotoxaemia in horses. Equine Veterinary Journal, 39, 243-248
https://doi.org/10.2746/042516407X173343
Pantaleon LG, Furr MO, McKenzie HC, Donaldson L (2007): Effects of small- and large-volume resuscitation on coagulation and electrolytes during experimental endotoxaemia in anesthetized horses. Journal of Veterinary Internal Medicine 21, 1374–1379.
Parnham MJ (2011): Immunomodulatory approaches to the treatment of infections. Croatian Journal of Infection 31, 15–27.
Patrick DH (1981): Systemic effects of Escherichia coli lipopolysaccharide-induced endotoxic shock in the horse. [PhD Thesis.] Iowa State University, USA. Retrospective Theses and Dissertations. Paper 6937.
Pritchard J.C., Lindberg A.C., Main D.C.J., Whay H.R. (2005): Assessment of the welfare of working horses, mules and donkeys, using health and behaviour parameters. Preventive Veterinary Medicine, 69, 265-283
https://doi.org/10.1016/j.prevetmed.2005.02.002
Radostits OM, Doreen HG, Houston M (2000): Veterinary Clinical Examination and Diagnosis. 1st edn. Elsevier Health Sciences. 800 pp.
Rosa P, Peiro J, Campebell R, Valadao C, Bechara G (2003): Effects of diclofenac and dexamethasone on horse experimental endotoxaemia. Arquivo Brasileiro de Medicina Veterinaria e Zootecnia 55, 279−286.
Tadros Elizabeth M., Frank Nicholas (2012): Effects of continuous or intermittent lipopolysaccharide administration for 48 hours on the systemic inflammatory response in horses. American Journal of Veterinary Research, 73, 1394-1402
https://doi.org/10.2460/ajvr.73.9.1394
Tóth Ferenc, Frank Nicholas, Elliott Sarah B., Geor Raymond J., Boston Raymond C. (2008): Effects of an intravenous endotoxin challenge on glucose and insulin dynamics in horses. American Journal of Veterinary Research, 69, 82-88
https://doi.org/10.2460/ajvr.69.1.82
Waage A., Halstensen A., Espevik T. (1987): ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASE. The Lancet, 329, 355-357
https://doi.org/10.1016/S0140-6736(87)91728-4
Watts Ashlee E., Ness Sally L., Divers Thomas J., Fubini Susan L., Frye Amelia H., Stokol Tracy, Cummings Kevin J., Brooks Marjory B. (2014): Effects of clopidogrel on horses with experimentally induced endotoxemia. American Journal of Veterinary Research, 75, 760-769
https://doi.org/10.2460/ajvr.75.8.760
